ArticleVaccines2021

Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains.

Ki-Back Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.